Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily.

Biotechnology

Lyndra Therapeutics

Kiera Henderson

Richard Scranton

Lindsay Beaupre

Klas Holmlund, CFA

Anna Legedza

Patrick Boen

Jessica Ballinger

Erik Ryde

Jonathan Raber

Liah Dukaye

Morgan Foster

Nicholas Barner

Roman Lovell

Michelle O'Connor

Samuel Chadwick

Kevin Acreman

Rosemary Kanasty

Colin Gardner

Maureen Chlopik

Giovanni Traverso

The Engineering and Scientific Research team at Lyndra Therapeutics develops innovative sustained-release drug delivery systems. Engineers and scientists collaborate to design, test, and optimize the ultra-long-acting oral therapies, focusing on formulation, analytical development, and process improvement to enhance patient adherence and therapeutic efficacy. The team integrates advanced engineering techniques with cutting-edge scientific research to pioneer a new era in medication administration.

Engineering and Scientific Research

Leadership Team

Clinical and Scientific Operations

Engineering and Scientific Research

About

Team members

Other teams at Lyndra Therapeutics

Leadership Team

Clinical and Scientific Operations